TiroSEEN

When tumor tissue isn’t available in sporadic MTC, can liquid biopsy help? A @ThyroidJournal study shows plasma ctDNA reliably detected RET mutations in progressive, high–tumor burden cases—supporting its use to possibly guide RET inhibitor therapy. ow.ly/aX0Y50Yx2Pe

Impact of Subtype Variability on Clinical Features in Papillary Thyroid Cancer * Los pacientes con subtipos mixtos tenían características clínicas más graves que aquellos con un solo subtipo, lo que sugiere que el tratamiento posoperatorio requiere precaución f.mtr.cool/olvtpprbrj @TiroSEEN

How do BRAFV600E & TERT cooperate in aggressive thyroid cancer? A new @ThyroidJournal study identifies DDX21 as the molecular link—upregulated via MEK/ERK/GABP, interacting with TERT to drive rRNA transcription and tumor progression. ow.ly/e1M150Ys4Bi @AmThyroidAssn

⏰ Abstract deadline approaching! Submit your abstract for the 47th @ETA_Thyroid Meeting in Porto, Portugal (5–8 Sept 2026). Present your work, connect with the international thyroid community. Accepted abstracts be published in the @Eur_Thyroid_J. 📅 Deadline: 16 March 2026

Chronic Iodine Excess and Aging Synergistically Impact Thyrotropin Elevation: A Prospective 20-Year Follow-Up Study in China - Xiaotong Gao, Weiping Li, Qingling Gu, Yushu Li, Yongze Li, Haoyu Wang, te al journals.sagepub.com/doi/10.1177/10…

📣 Exciting news! All Thyroid® articles are FREE to read through the end of March! Dive into the latest research on #thyroid health and stay informed about important findings. Don't miss out on this opportunity to expand your knowledge! Learn more: ow.ly/j1eE50Ykq2S

Real-world data show limited efficacy of sequential cabozantinib treatment in RAIR-(P)DTC *Cabozantinib ha mejorado significativamente la supervivencia libre de progresión en pacientes con #CDT refractario al yodo radiactivo después del pretratamiento con lenvatinib y/o sorafenib en el ensayo de fase 3 COSMIC-311, lo que llevó a su aprobación para el tratamiento secuencial f.mtr.cool/avxffrnhhm @TiroSEEN

DYRK1A Expression and Thyroid Dysfunction in Subjects With Down Syndrome * La expresión de DYRK1A está sobreexpresada en individuos con síndrome de Down con hipotiroidismo, que abarca tanto las formas autoinmunes de aparición temprana como las autoinmunes de aparición tardía. f.mtr.cool/ggmulocfzg @TiroSEEN

Lower Serum Triiodothyronine Levels Constitute an Independent Risk Factor for Dyslipidemia in Levothyroxin-Treated Patients * Los niveles bajos de T3L en pacientes tratados con LT4 representan un factor de riesgo independiente de #dislipidemia, incluso con niveles normales de TSH f.mtr.cool/hmyevfhczd @LipidoSEEN @TiroSEEN

One Year Cholecalciferol and Calcium Supplementation Improve BMD But Not Trabecular Bone Score in Asymptomatic Hypovitaminosis D * Un año de suplementación con colecalciferol y calcio en individuos asintomáticos resultó en un aumento significativo del 25(OH)D sérico, que se asoció con un aumento de la DMO pero no del TBS f.mtr.cool/oeyrzudhzk @oseoseen

Daniele Ceruti et al. evaluates 2 reference cohorts of patients with sporadic MTC treated at tertiary referral centres in 2 European countries - Italy, where routine CT measurement is included in diagnostic work‑up, & the Netherlands, where it's not. 🔗 doi.org/10.1530/ETJ-25…

A PTH Value at 6 Hours Postsurgery Predicts the Diagnosis of Transient and Permanent Hypoparathyroidism  * La medición de los niveles de PTH a las 6 horas postiroidectomía es un método preciso para predecir qué pacientes corren el riesgo de desarrollar #hipoparatiroidismo transitorio y/o permanente f.mtr.cool/toypgtydqi @oseoseen

Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy? - Dana Hamadi, Suhail Saad-Omer, David Toro-Tobon, Marius N. Stan, 2026 journals.sagepub.com/doi/10.1177/10…

Outcomes of Patients with RAS-Positive Bethesda III and IV Cytology Thyroid Nodules - Jiahui Wu, Caitlin Yeo, Jackson Qi, Sana Ghaznavi, Moosa Khalil, Erik Nohr, Adrian Box, Markus Eszlinger, Ralf Paschke, 2026 journals.sagepub.com/doi/10.1177/10…

A new review highlights the significant progress that has been made in the management of thyroid eye disease, attributed to the elucidation of important pathogenic mechanisms and the development of new therapeutics validated in randomised clinical trials. doi.org/10.1530/ETJ-25…

An expert commentary explores the findings of the GRASS trial - a randomized, double-blind, placebo-controlled, multicenter study evaluating selenium's impact on remission rates and quality of life in patients with Graves’ disease. Read the research: doi.org/10.1530/ETJ-26…

What is the risk of hypothyroidism after hemithyroidectomy in children? What if you carry TPO antibodies? New study from @BostonChildrens who found ~28% develop persistent hypothyroidism with higher risk if TSH ≥2 and + TPO antibodies. ow.ly/gtUq50Y1TpW @AmThyroidAssn

The Incidence of Cardiovascular Disease Events in Women with Hypothyroidism: The Study of Women’s Health Across the Nation - No se observó aumento de eventos CV en mujeres tratadas con levotiroxina respecto a mujeres eutiroideas. journals.sagepub.com/doi/10.1177/10…

Long-Term Thyroid Toxicity Burden in Children Who Received Treatment for High-Risk Neuroblastoma - Riesgo especialmente alto si uso de RT, Inmunoterapia o Busulfan. A 10 años afectación del 50% journals.sagepub.com/doi/10.1177/10…

“For some things to remain the same, everything must change.” ATA 2025 guidelines have redefined Excellent Response in thyroid cancer patients not treated with I-131. Is this evolution justified? What does it mean for clinical practice? Explore with us! link.springer.com/article/10.100…